Back to Search
Start Over
High Propensity to Switch to Long-acting Injectable HIV PrEP with Cabotegravir in a Cohort of Oral PrEP Experienced Men who Have Sex with Men in Italy.
- Source :
- AIDS & Behavior; Mar2024, Vol. 28 Issue 3, p907-911, 5p
- Publication Year :
- 2024
-
Abstract
- Aim was to investigate the propensity to switch to long-acting injectable HIV pre-exposure prophylaxis (PrEP) with cabotegravir among oral PrEP-experienced men who have sex with men. Out of 377 PrEP users, 325 (86.2%) were interested (would like = 210) or considering (would consider = 115) switch to long-acting PrEP. At multivariable analysis, the odds ratio of interest in long-acting PrEP in non-adherent vs. adherent individuals to oral PrEP was 5.03 (95%CI = 1.73–14.61,p = 0.003) and of consideration 1.63 (95%CI = 0.51–5.23,p = 0.410). We observed very high propensity to switch to long-acting PrEP, particularly among non-adherent users. Rapid availability of long-acting PrEP might address unmet needs of PrEP users in Italy. [ABSTRACT FROM AUTHOR]
- Subjects :
- HIV prevention
GENERIC drug substitution
HIV integrase inhibitors
CONFIDENCE intervals
ORAL drug administration
MULTIVARIATE analysis
INTRAMUSCULAR injections
PRE-exposure prophylaxis
EMTRICITABINE-tenofovir
DESCRIPTIVE statistics
DRUGS
MEN who have sex with men
ODDS ratio
PATIENT compliance
LONGITUDINAL method
PROBABILITY theory
MEDICAL needs assessment
Subjects
Details
- Language :
- English
- ISSN :
- 10907165
- Volume :
- 28
- Issue :
- 3
- Database :
- Complementary Index
- Journal :
- AIDS & Behavior
- Publication Type :
- Academic Journal
- Accession number :
- 175676026
- Full Text :
- https://doi.org/10.1007/s10461-023-04197-8